Carregant...
Long-term Outcomes with Ambrisentan Monotherapy in Pulmonary Arterial Hypertension
INTRODUCTION: This study evaluated long-term outcomes in patients with pulmonary arterial hypertension (PAH) undergoing treatment with ambrisentan monotherapy, a selective oral endothelin-1 receptor antagonist. METHODS: Patients who participated in the ARIES-1 clinical trial and extension phase at o...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2819977/ https://ncbi.nlm.nih.gov/pubmed/20142023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2009.09.008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|